However, from the methodological perspective, the results of our models might be more applicable to depression than to generalized anxiety, as most of the sample with elevated generalized anxiety levels also showed elevated depressive symptoms, whereas only 11% of the sample had elevated GAD symptoms alone (compared to 26% of the sample having elevated depressive symptoms only). The gene discussed is GAD1; the disease is depressive symptom measurement.